Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Timothy P. Hofer"'
Autor:
Garth W. Strohbehn, Robert Holleman, Jennifer Burns, Mandi L. Klamerus, Michael J. Kelley, Eve A. Kerr, Nithya Ramnath, Timothy P. Hofer
Publikováno v:
JAMA oncology. 8(11)
ImportanceExtended-interval dosing of pembrolizumab (400 mg every 6 weeks) was approved by US Food and Drug Administration (FDA) in April 2020 as an alternative to standard-interval dosing (200 mg every 3 weeks). Extended-interval dosing may enhance
Autor:
Allison W. Kurian, Paul Abrahamse, Kevin C. Ward, Ann S. Hamilton, Dennis Deapen, Jonathan S. Berek, Lily Hoang, Amal Yussuf, Jill Dolinsky, Krystal Brown, Thomas Slavin, Timothy P. Hofer, Steven J. Katz
Publikováno v:
JCO Precis Oncol
PURPOSE Family cancer history is an important component of genetic testing guidelines that estimate which patients with breast cancer are most likely to carry a germline pathogenic variant (PV). However, we do not know whether more extensive family h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2736c2ada75f49bcc08deae9fff4ebe4
https://europepmc.org/articles/PMC8710333/
https://europepmc.org/articles/PMC8710333/
Improving Breast Cancer Surgical Treatment Decision Making: The iCanDecide Randomized Clinical Trial
Autor:
Steven J. Katz, Angela Fagerlin, Sarah T. Hawley, Yun Li, Michael S. Sabel, Nancy K. Janz, Reshma Jagsi, Lawrence C. An, Monica Morrow, Timothy P. Hofer, Kevin C. Ward, Ken Resnicow
Publikováno v:
Journal of Clinical Oncology. 36:659-666
Purpose This study was conducted to determine the effect of iCanDecide, an interactive and tailored breast cancer treatment decision tool, on the rate of high-quality patient decisions—both informed and values concordant—regarding locoregional br
Autor:
Reshma Jagsi, Kevin C. Ward, Timothy P. Hofer, Steven J. Katz, Irina Bondarenko, Sarah T. Hawley, Allison W. Kurian
Publikováno v:
Breast cancer research and treatment. 165(3)
We know little about whether it matters which oncologist a breast cancer patient sees with regard to receipt of chemotherapy. We examined oncologists’ influence on use of recurrence score (RS) testing and chemotherapy in the community. We identifie
Autor:
Steven J. Katz, Ann S. Hamilton, Kevin C. Ward, Paul Abrahamse, Reshma Jagsi, Allison W. Kurian, Monica Morrow, Timothy P. Hofer
Publikováno v:
JAMA oncology. 3(10)
Surgery after initial lumpectomy to obtain more widely clear margins is common and may lead to mastectomy.To describe surgeons' approach to surgical margins for invasive breast cancer, and changes in postlumpectomy surgery rates, and final surgical t
Autor:
Steven J. Katz, Ann S. Hamilton, Sarah T. Hawley, Kevin C. Ward, M. Chandler McLeod, Reshma Jagsi, Irina Bondarenko, Timothy P. Hofer, Allison W. Kurian, Christopher R. Friese
Publikováno v:
Journal of the National Cancer Institute. 110(5)
Background There is growing concern about overtreatment of breast cancer as outcomes have improved over time. However, little is known about how chemotherapy use and oncologists' recommendations have changed in recent years. Methods We surveyed 5080
Autor:
Steven J. Katz, Ann S. Hamilton, Kevin C. Ward, Yun Li, Irina Bondarenko, Jeremy M. G. Taylor, Allison W. Kurian, Reshma Jagsi, Timothy P. Hofer
Publikováno v:
Breast cancer research and treatment. 161(3)
To quantify the influence of RS assay on changing chemotherapy plans in a general practice setting using causal inference methods.We surveyed 3880 newly diagnosed breast cancer patients in Los Angeles and Georgia in 2013-14. We used inverse propensit
Autor:
Ann S. Hamilton, Steven J. Katz, Donna Morrell, Timothy P. Hofer, Meryl Leventhal, Dennis Deapen, Barbara Salem, Sarah T. Hawley
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 18:2022-2029
Purpose: Latinas and African-Americans with breast cancer, especially those of lower socioeconomic status and acculturation, have been underrepresented in studies assessing treatment satisfaction, decision-making, and quality of life. A study was des
Autor:
Timothy P. Hofer, Sarah T. Hawley, Steven J. Katz, Lihua Liu, Kendra Schwartz, Dennis Deapen, Nancy K. Janz, Paula M. Lantz, Monica Morrow
Publikováno v:
Journal of Clinical Oncology. 25:271-276
Purpose Characteristics of surgeons and their hospitals have been associated with cancer treatments and outcomes. However, little is known about factors that are associated with referral pathways. Methods We analyzed tumor registry and survey data fr